These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25192907)
1. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy. Yuste JR; Quesada M; Díaz-Rada P; Del Pozo JL Int J Infect Dis; 2014 Oct; 27():65-6. PubMed ID: 25192907 [TBL] [Abstract][Full Text] [Related]
2. A case of Enterococcus faecalis prosthetic joint infection: a rare and difficult infection to treat. Ching CK; Fraser SL; Wortmann GW Hawaii Med J; 2006 Sep; 65(9):264-5, 273. PubMed ID: 17153671 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria. Perrottet N; Steinrücken J; Chan M; Pannatier A; Borens O; Yusuf E; Trampuz A Int J Antimicrob Agents; 2015 Oct; 46(4):480-2. PubMed ID: 26235888 [No Abstract] [Full Text] [Related]
4. Administration interval and daptomycin toxicity: a case report of rhabdomyolysis. Sbrana F; Di Paolo A; Pasanisi EM; Tagliaferri E; Arvia C; Puntoni M; Leonildi A; Bigazzi F; Danesi R; Rovai D; Tascini C; Menichetti F J Chemother; 2010 Dec; 22(6):434-5. PubMed ID: 21303756 [No Abstract] [Full Text] [Related]
5. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Furustrand Tafin U; Majic I; Zalila Belkhodja C; Betrisey B; Corvec S; Zimmerli W; Trampuz A Antimicrob Agents Chemother; 2011 Oct; 55(10):4821-7. PubMed ID: 21807979 [TBL] [Abstract][Full Text] [Related]
6. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE). Mohr JF; Friedrich LV; Yankelev S; Lamp KC Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165 [TBL] [Abstract][Full Text] [Related]
7. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis. Sepandj F; Ceri H; Gibb A; Read R; Olson M Perit Dial Int; 2007; 27(4):464-5. PubMed ID: 17602158 [No Abstract] [Full Text] [Related]
9. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary? King EA; McCoy D; Desai S; Nyirenda T; Bicking K J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178 [TBL] [Abstract][Full Text] [Related]
10. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA; Mickail N; Eisenstein L Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808 [TBL] [Abstract][Full Text] [Related]
11. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. Stone PA; Armstrong PA; Bandyk DF; Brumberg RS; Flaherty SK; Back MR; Johnson BL; Shames ML J Vasc Surg; 2006 Oct; 44(4):757-61. PubMed ID: 17012000 [TBL] [Abstract][Full Text] [Related]
12. Is combination systemic therapy superior to monotherapy for enterococcal prosthetic joint infection? Nsutebu EF; Hobson R Clin Infect Dis; 2009 Feb; 48(4):495; author reply 495-6. PubMed ID: 19586378 [No Abstract] [Full Text] [Related]
13. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384 [TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403 [TBL] [Abstract][Full Text] [Related]
15. Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence? Cai T; Mazzoli S; Malossini G; Bartoletti R J Antimicrob Chemother; 2011 May; 66(5):1195-6; author reply 1196-7. PubMed ID: 21186192 [No Abstract] [Full Text] [Related]
16. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections. Herrera S; Sorlí L; Horcajada JP Med Clin (Barc); 2017 Sep; 149(5):223-224. PubMed ID: 28602211 [No Abstract] [Full Text] [Related]
17. Successful clinical use of daptomycin-impregnated bone cement in two-stage revision hip surgery for prosthetic joint infection. Cortes NJ; Lloyd JM; Koziol L; O'Hara L Ann Pharmacother; 2013 Jan; 47(1):e2. PubMed ID: 23324502 [TBL] [Abstract][Full Text] [Related]
18. Haematogenous infection of a resurfacing hip replacement after transurethral resection of the prostate. Dabasia H; Kokkinakis M; El-Guindi M J Bone Joint Surg Br; 2009 Jun; 91(6):820-1. PubMed ID: 19483240 [TBL] [Abstract][Full Text] [Related]
19. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium. Mueller SW; Kiser TH; Anderson TA; Neumann RT Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018 [TBL] [Abstract][Full Text] [Related]
20. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Rao N; Regalla DM Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]